Biocept inc (BIOC)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash Flows from Operating Activities
Net loss

-8,341

-5,713

-5,691

-7,816

-5,916

-6,013

-6,047

-6,153

-6,356

-5,666

-5,821

-5,693

-4,432

-4,186

-4,743

-4,594

-4,875

-4,617

-4,496

-4,035

-3,800

-3,881

-3,859

-2,996

-5,127

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

242

240

240

228

222

220

223

177

179

181

168

109

116

75

88

80

77

73

73

61

52

73

65

54

57

Amortization of right-of-use assets

-48

-44

-37

-37

-37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory reserve

-25

6

-11

-8

-0

-53

23

54

14

28

-6

-0

29

-9

3

23

13

14

5

16

-1

-

-

-

-

Inventory reserve

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

Stock-based compensation

142

244

297

224

102

111

113

173

225

15

475

383

373

428

465

330

368

361

339

342

334

316

321

290

894

Non-cash interest expense related to credit facility and other financing activities

-

-

-

-

-

0

-2

13

18

21

17

3

3

39

28

8

24

26

24

40

28

16

31

13

1,382

Warrant inducement expense

2,102

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-3

-2

206

Increase/(decrease) in cash resulting from changes in:
Accounts receivable, net

-108

665

652

331

303

97

38

107

136

60

138

159

705

43

-0

43

9

-6

8

16

5

-1

-16

2

16

Inventory

175

74

93

36

-9

59

20

-8

-22

-304

150

106

-53

60

-1

105

3

33

42

24

26

35

4

38

3

Prepaid expenses and other current assets

133

-200

-89

-77

-155

-210

-218

-259

199

-87

-211

-121

-97

6

-237

-271

7

-100

-132

-141

455

-127

-15

151

393

Accounts payable

412

213

-126

-224

152

188

-22

231

204

-158

-157

329

335

-659

629

98

264

-193

189

-384

336

10

-126

-34

-830

Accrued liabilities

385

133

356

-646

367

-36

425

-436

508

-434

466

-262

466

12

316

-372

208

22

33

3

181

130

79

15

-1,272

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

22

20

15

13

45

29

20

-

-

-

-

Deferred rent

-

-

-

-

-

-34

-27

-27

-27

-24

-17

-17

-17

-14

-7

-7

-7

-4

1

1

1

4

11

11

11

Net cash used in operating activities

-5,278

-5,471

-5,607

-6,722

-5,247

-5,418

-5,454

-5,906

-5,576

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows from Investing Activities:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-3,739

-4,439

-2,963

-4,336

-3,957

-4,258

-3,711

-3,855

-3,329

-3,218

-3,429

-2,834

-5,093

Purchases of fixed assets

18

437

211

53

32

0

72

18

53

344

528

400

127

90

67

233

90

46

46

47

25

-

-

-

-

Net cash used in investing activities

-18

-437

-211

-53

-32

0

-72

-18

-53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows from Financing Activities:
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-127

-60

-67

-233

-90

-46

-46

-47

-25

-

-

-

-

Net proceeds from issuance of common stock and warrants

14,659

8,965

0

-1

16,781

5

12,345

0

13,342

2,921

2,023

0

8,559

8,972

141

4,333

324

-

-

-

-

-

-

-

-

Net proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,390

Proceeds from exercise of common stock warrants

2,306

0

0

2,508

4

1

0

0

0

0

5

2,234

5,258

-

-

-

-

62

30

1,185

8,482

-

-

-

-

Payments on finance leases

136

161

101

110

166

0

49

72

38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of overallotment warrants

659

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on equipment financings

-

-

-

-

-

-

-

-

-

56

64

32

12

-0

37

25

23

-

-

-

-

-

-

-

-

Payments on equipment financings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

-

-

-

-

Payments on supplier and other third-party financings

-

-

-

-

-

120

208

189

40

151

119

156

37

82

145

165

116

37

0

16

16

29

6

13

142

Payments on credit facility

-

-

-

-

-

0

172

517

508

498

488

478

469

460

0

393

385

-

-

-

-

0

0

0

2,346

Net cash provided by financing activities

17,489

8,671

-232

4,604

16,619

-114

11,914

-778

12,755

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in Cash

12,191

-

-

-

11,338

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

365

Proceeds from issuance of convertible notes and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

175

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

13,299

8,430

-41

3,748

-201

584

-224

1,132

17,285

-43

-16

4,884

15,441

Net increase in Cash

-

-

-

-

-

-

-

-6,703

7,125

-3,732

-4,121

-4,042

9,433

3,930

-3,072

-821

-4,248

-

-

-

-

-

-

-

-

Net increase (decrease) in Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,982

-2,770

13,930

-3,455

-3,640

2,043

10,348

Supplemental Disclosures of Cash Flow Information:
Cash paid during the period for:
Interest

56

62

62

63

61

225

244

70

63

73

60

132

92

76

94

89

97

96

103

102

103

103

102

43

152

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

0

0

0

1

-

-

-

-

Gross proceeds from offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

8,833

-

-

-

-